Lilly wins court ban on generic copy of Gemzar
Eli Lilly and Co. won a U.S. court ruling Wednesday that bars Teva Pharmaceutical Industries Ltd. from selling a generic version
of the cancer drug Gemzar until November.
Bloomberg News
Articles
Lilly drug wins U.K. backing as cancer therapy
Eli Lilly and Co.’s Alimta has received the preliminary backing of a United Kingdom agency as a maintenance treatment for
patients with the most common form of lung cancer.
General Growth’s bankruptcy plan makes room for Simon
The provision would give General Growth time to explore a takeover bid from Simon Property Group Inc., whose $10 billion offer
was turned down by its rival in February. Simon is preparing a new bid, according to a person with knowledge of that plan.
General Growth preparing to file finance plan
General Growth is weighing options to exit Chapter 11 protection, with competing bids from Indianapolis-based Simon Property
Group Inc. and Brookfield Asset Management Inc.
Lilly sues Hospira over generic version of Gemzar
Indianapolis-based Eli Lilly and Co. sued rival drugmaker Hospira Inc. to prevent it from selling a generic version of the
cancer drug Gemzar before a patent on the medicine expires in 2013.
Another General Growth suitor enters fray
Elliott Associates LP and Paulson & Co. are said to be discussing a plan to team with Brookfield Asset Management Inc. to
bring mall owner General Growth Properties Inc. out of bankruptcy, competing with Simon Property Group.
Ariad loses $65M patent appeal against Eli Lilly
Monday’s decision throws out a $65.2 million patent-infringement verdict won by Ariad for royalties on Lilly’s osteoporosis
drug Evista and sepsis medicine Xigris.
ITT ‘buying accreditation’ strategy makes critics uneasy
ITT Educational Services and other for-profit educators are buying not-for-profit colleges to gain access to their regional
accreditation. The tactic could fuel rapid growth but makes critics uncomfortable.
Lilly sues to block generic of Adcirca lung treatment
Netherlands-based Synthon Pharmaceuticals is seeking U.S. Food and Drug Administration approval to sell a copy of the medicine.
Cummins expects profit to grow 10 percent a year
Columbus-based Cummins Inc., North America’s largest maker of heavy-duty diesel truck engines, expects pretax profit
to increase 10 percent a year and sales to grow 13 percent annually over the next five years.
Lilly buys right to underarm lotion for low sex drive
Eli Lilly & Co., the maker of the impotence pill Cialis, bought exclusive rights from Australia’s Acrux Ltd. to
an underarm testosterone lotion called Axiron for men with limited sex drive due to low levels of the hormone.
Lilly pays $50M-plus for rights to testosterone lotion
Indianapolis-based Lilly will pay Acrux of West Melbourne, Australia, a $50 million license fee, plus $3 million when manufacturing
assets are transferred, but the deal could be worth millions more.
Simon says new General Growth plan is less uncertain
A new plan by mall owner General Growth Properties Inc. to exit bankruptcy resolves some uncertainty rival bidder Simon Property
Group Inc. has criticized, Simon CEO David Simon says.
General Growth investors add $3.93B to Brookfield plan
The cash payment matches a provision of a competing bid by Indianapolis-based Simon Property Group Inc., which has offered
to buy its biggest competitor for more than $10 billion and pay all unsecured creditors.
Creditors: General Growth biased toward Brookfield proposal
General Growth Properties Inc. may favor a risky bid from Brookfield Asset Management Inc. because of that company’s
agreement with William Ackman’s Pershing Square Capital Management LP, creditors said in court documents. Simon Property
Group also has bid to acquire the bankrupt company.
General Growth sets timeline for reorganization, plans IPO
General Growth, the bankrupt takeover target of Simon Property Group, aims to confirm a reorganization plan by Oct. 5. In addition, it said it will launch an initial public offering on Friday.
Regulators take interest in Simon’s play for Prime Outlets
The Federal Trade Commission has contacted Gap Inc. about Simon Property Group's proposed acquisition of Prime Outlets
Acquisition Co.
General Growth seeks to block lawsuit over Simon bid
General Growth Properties Inc. asked a judge to block a shareholder lawsuit accusing its board of improperly rejecting an
acquisition bid from Simon Property Group Inc.
WellPoint records subpoened in California probe
The California attorney general has demanded documents from several health insurers, including Indianapolis' WellPoint,
believing that their rate-setting and claims practices might be illegal.
Study: Hospital clout spurs higher Calif. health costs
While insurers get the blame for rising health-care costs for consumers, surging fees from hospitals and the growing dominance
of such providers may be just as responsible for driving up expenses, according to a new study examining California's
market.